Compare Immunovant Inc. Common Stock (IMVT) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.5 (market cap $5.85B). The key difference: Immunovant Inc. Common Stock and Iovance Biotherapeutics Inc. Common Stock are close in size by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| IMVT | IOVA | |
|---|---|---|
Market Cap | $6.62B | $5.85B |
Volume | 1,131,364 | 14,517,176 |
Sector | Health | Health |
52-Week High | $44.96 | $14.82 |
52-Week Low | $17.03 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $5.78B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
